Clinical specialty

Otolaryngology

PubMed literature and news, the drugs tagged Otolaryngology and their dated catalysts.

Literature and news

All Otolaryngology stories

Literature items come from PubMed, and each one links to its PubMed record. HealthTrade shows the citation only: abstracts are not reproduced, because they stay under the publisher's copyright.

  1. Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations. (opens in a new tab)

    Lancet Oncol, 2026 Nov · PubMed

    Systematic Review in The Lancet. Oncology, 2026 Nov. PubMed ID 42933448.

    Comments on Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations.

No drugs are tagged Otolaryngology yet. Editors tag each drug with its specialties.

Showing the next 30 days. Pro shows every date.

1 Nov 2026 to 1 Dec 2026, US Eastern dates. Compare plans

No dated catalysts for Otolaryngology drugs in this range.

Dates come from company and FDA disclosures and can change. Each row links to its source.

Literature: PubMed, U.S. National Library of Medicine. Trial data: ClinicalTrials.gov. FDA data provided by the U.S. Food and Drug Administration. Nothing here is investment advice.